Daxor Corp. (DXR) intrinsic value & 10-year financials

Daxor Corp. (DXR) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 3 fiscal years revenue shrank 8.4% a year to $1.4M, with an average return on invested capital of -7.6%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$10.05
Revenue (FY2011)
$1.4M
Revenue growth (3-yr CAGR)
-8.4%
ROIC (10-yr avg)
-7.6%
Free cash flow (FY2011)
-$6.6M

DXR 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2011 $1.4M -$7.2M — -$6.6M -400.1% -8.1%
FY2010 $1.6M $5.0M — -$6.0M -358.3% -7.2%
FY2009 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

DAXOR CORP revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

DAXOR CORP has historically struggled to out-earn its cost of capital, averaging just -7.6% ROIC.

DAXOR CORP capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, DAXOR CORP is modeled at -8.4% normalized earnings growth with a 5.1% bond-yield adjustment.

DXR stock: frequently asked questions

Does Daxor Corp. generate free cash flow?

Daxor Corp. generated -$6.6M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2011. Free cash flow was positive in 0 of the last 2 reported years.

What is DXR's return on invested capital?

Average ROIC over the last 3 fiscal years was -7.6%, and average return on equity was -3.4%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this DXR data come from?

From Daxor Corp.'s annual 10-K filings on SEC EDGAR, most recently filed Mar 28, 2012. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.